Active Ingredient(s):Filgrastim-ayow FDA Approved: * February 25, 2022 Pharm Company: *KASHIV BIOSCIENCES LLC Category:Cancer
Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low neutrophil count. Low neutrophil counts may occur with HIV/AIDS, following chemotherapy or radiation poisoning, or be of an unknown cause. It may also be used to increase white blood cells for gathering during leukapheresis. It is given either by injection into a vein or under the skin.
Common side effects include fever, cou...
* May have multiple approval dates, manufacturers, or labelers.